APSR2026-988

 
Late-Breaking
Submitted
Poster Presentation
 
AP14-085
P104
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1240557-46904-case_433602.pdf
Format: PDF Only
08. Lung Cancer
8

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Boqiang Wang * Tianjin Medical University General Hospital Department of Medical Oncology Tianjin China
Lingping Kong - Tianjin Medical University General Hospital Department of Medical Oncology Tianjin China
Xin Wang - Tianjin Medical University General Hospital Department of Medical Oncology Tianjin China
Tao Yu - Tianjin Medical University General Hospital Department of Medical Oncology Tianjin China
Junping Wang - Tianjin Medical University General Hospital Department of Imaging Tianjin China
Chunsheng Yang - Tianjin Medical University General Hospital Department of Neurology Tianjin China
Linlin Zhang - Tianjin Medical University General Hospital Department of Medical Oncology Tianjin China
Diansheng Zhong - Tianjin Medical University General Hospital Department of Medical Oncology Tianjin China
 
 
 
 
 
 
 
Presenting Author Details
Boqiang
Wang
wmyc4733897@163.com
+8618322005185
Under 30
China
Case Report
Mycophenolate Mofetil for Steroid-Refractory ICI-Associated Transverse Myelitis in Biphasic Pleural Mesothelioma
Maximum 25 words
Abstract Content
 
 
 
 
Biphasic malignant pleural mesothelioma (MPM) is a rare thoracic tumor prone to severe immune-related adverse events after dual immunotherapy. Immune checkpoint inhibitor (ICI)-associated transverse myelitis (TM) is a rare severe neurological irAE with incidence less than 0.01%, and management of steroid-refractory cases remains challenging.
We report a 37-year-old male with biphasic pleural mesothelioma who developed ICI-related TM following treatment with nivolumab (anti-PD-1) plus ipilimumab (anti-CTLA-4). Initial high-dose glucocorticoids combined with intravenous immunoglobulin (IVIg) failed to control neurological impairment. After adding mycophenolate mofetil (MMF) to steroid treatment for one month, the patient’s neurological function mildly improved and abnormal spinal MRI enhancement resolved significantly, while irreversible spinal cavitation remained. Subsequently, the patient switched to pemetrexed plus carboplatin chemotherapy with stable tumor control.
Based on published case series and systematic reviews, our report indicates MMF is a promising second-line choice for steroid-refractory ICI-induced TM in MPM patients and provides practical clinical reference for this rare complication.
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Immune checkpoint inhibitors, Pleural mesothelioma, Transverse myelitis
maximum 3 keywords and no abbreviations, separated by commas
 
155